nodes	percent_of_prediction	percent_of_DWPC	metapath
Antipyrine—CYP2C9—brain cancer	0.508	1	CbGaD
Antipyrine—CYP2D6—Lomustine—brain cancer	0.0528	0.145	CbGbCtD
Antipyrine—CYP1A2—Carmustine—brain cancer	0.0522	0.143	CbGbCtD
Antipyrine—PTGS2—Etoposide—brain cancer	0.041	0.113	CbGbCtD
Antipyrine—CYP2D6—Hydroxyurea—brain cancer	0.04	0.11	CbGbCtD
Antipyrine—CYP3A4—Temozolomide—brain cancer	0.0395	0.108	CbGbCtD
Antipyrine—PTGS1—Etoposide—brain cancer	0.0347	0.0952	CbGbCtD
Antipyrine—CYP3A4—Lomustine—brain cancer	0.0336	0.0922	CbGbCtD
Antipyrine—CYP2E1—Etoposide—brain cancer	0.0268	0.0735	CbGbCtD
Antipyrine—CYP2C8—Etoposide—brain cancer	0.02	0.0549	CbGbCtD
Antipyrine—TRPA1—trigeminal nerve—brain cancer	0.0189	0.31	CbGeAlD
Antipyrine—CYP1A2—Etoposide—brain cancer	0.0155	0.0425	CbGbCtD
Antipyrine—TRPA1—cranial nerve—brain cancer	0.0135	0.221	CbGeAlD
Antipyrine—CYP3A4—Etoposide—brain cancer	0.00811	0.0223	CbGbCtD
Antipyrine—TRPA1—ganglion—brain cancer	0.00681	0.112	CbGeAlD
Antipyrine—TRPA1—TRP channels—TRPC6—brain cancer	0.00347	0.0537	CbGpPWpGaD
Antipyrine—Aminophenazone—CYP2C9—brain cancer	0.00213	1	CrCbGaD
Antipyrine—TRPA1—spinal cord—brain cancer	0.00184	0.0302	CbGeAlD
Antipyrine—CYP2C18—Xenobiotics—CYP2C9—brain cancer	0.00179	0.0278	CbGpPWpGaD
Antipyrine—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.00176	0.0273	CbGpPWpGaD
Antipyrine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00173	0.0268	CbGpPWpGaD
Antipyrine—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00155	0.0241	CbGpPWpGaD
Antipyrine—TRPA1—central nervous system—brain cancer	0.00149	0.0245	CbGeAlD
Antipyrine—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00146	0.0225	CbGpPWpGaD
Antipyrine—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00142	0.022	CbGpPWpGaD
Antipyrine—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00141	0.0219	CbGpPWpGaD
Antipyrine—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.00139	0.0216	CbGpPWpGaD
Antipyrine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00139	0.0215	CbGpPWpGaD
Antipyrine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00126	0.0196	CbGpPWpGaD
Antipyrine—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.0012	0.0187	CbGpPWpGaD
Antipyrine—TRPA1—Stimuli-sensing channels—TRPC6—brain cancer	0.00119	0.0185	CbGpPWpGaD
Antipyrine—PTGS2—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00116	0.0179	CbGpPWpGaD
Antipyrine—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.00109	0.0169	CbGpPWpGaD
Antipyrine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00108	0.0167	CbGpPWpGaD
Antipyrine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00108	0.0167	CbGpPWpGaD
Antipyrine—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00105	0.0163	CbGpPWpGaD
Antipyrine—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00101	0.0156	CbGpPWpGaD
Antipyrine—PTGS1—ganglion—brain cancer	0.000992	0.0163	CbGeAlD
Antipyrine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000989	0.0153	CbGpPWpGaD
Antipyrine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000984	0.0152	CbGpPWpGaD
Antipyrine—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000882	0.0137	CbGpPWpGaD
Antipyrine—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.000864	0.0134	CbGpPWpGaD
Antipyrine—PTGS1—endothelium—brain cancer	0.000855	0.014	CbGeAlD
Antipyrine—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000831	0.0129	CbGpPWpGaD
Antipyrine—PTGS2—endothelium—brain cancer	0.000818	0.0134	CbGeAlD
Antipyrine—CYP2C18—endocrine gland—brain cancer	0.000802	0.0132	CbGeAlD
Antipyrine—PTGS2—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.000801	0.0124	CbGpPWpGaD
Antipyrine—PTGS1—blood vessel—brain cancer	0.000789	0.013	CbGeAlD
Antipyrine—TRPA1—Ion channel transport—TRPC6—brain cancer	0.000778	0.012	CbGpPWpGaD
Antipyrine—PTGS2—blood vessel—brain cancer	0.000754	0.0124	CbGeAlD
Antipyrine—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000751	0.0116	CbGpPWpGaD
Antipyrine—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000747	0.0116	CbGpPWpGaD
Antipyrine—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000745	0.0115	CbGpPWpGaD
Antipyrine—CYP2C18—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000735	0.0114	CbGpPWpGaD
Antipyrine—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000718	0.0111	CbGpPWpGaD
Antipyrine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000667	0.0103	CbGpPWpGaD
Antipyrine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000641	0.00993	CbGpPWpGaD
Antipyrine—CYP2D6—hindbrain—brain cancer	0.000618	0.0102	CbGeAlD
Antipyrine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000613	0.00949	CbGpPWpGaD
Antipyrine—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000606	0.00938	CbGpPWpGaD
Antipyrine—CYP2C18—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000604	0.00935	CbGpPWpGaD
Antipyrine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00059	0.00913	CbGpPWpGaD
Antipyrine—TRPA1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000586	0.00908	CbGpPWpGaD
Antipyrine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000577	0.00893	CbGpPWpGaD
Antipyrine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000565	0.00875	CbGpPWpGaD
Antipyrine—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000556	0.0086	CbGpPWpGaD
Antipyrine—CYP2C18—FOXA1 transcription factor network—SHH—brain cancer	0.000552	0.00855	CbGpPWpGaD
Antipyrine—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000519	0.00804	CbGpPWpGaD
Antipyrine—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.0005	0.00774	CbGpPWpGaD
Antipyrine—SLC22A6—brain—brain cancer	0.000486	0.00798	CbGeAlD
Antipyrine—CYP2A6—cerebellum—brain cancer	0.000467	0.00767	CbGeAlD
Antipyrine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000458	0.00709	CbGpPWpGaD
Antipyrine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000454	0.00703	CbGpPWpGaD
Antipyrine—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000448	0.00694	CbGpPWpGaD
Antipyrine—PTGS2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000441	0.00683	CbGpPWpGaD
Antipyrine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000401	0.00621	CbGpPWpGaD
Antipyrine—CYP2E1—telencephalon—brain cancer	0.000397	0.00652	CbGeAlD
Antipyrine—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000389	0.00603	CbGpPWpGaD
Antipyrine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000386	0.00597	CbGpPWpGaD
Antipyrine—CYP2C8—pituitary gland—brain cancer	0.000384	0.00631	CbGeAlD
Antipyrine—PTGS1—telencephalon—brain cancer	0.000383	0.00628	CbGeAlD
Antipyrine—CYP2A6—brain—brain cancer	0.000379	0.00623	CbGeAlD
Antipyrine—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000368	0.0057	CbGpPWpGaD
Antipyrine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000366	0.00567	CbGpPWpGaD
Antipyrine—PTGS2—telencephalon—brain cancer	0.000366	0.00601	CbGeAlD
Antipyrine—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000362	0.0056	CbGpPWpGaD
Antipyrine—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000359	0.00556	CbGpPWpGaD
Antipyrine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000359	0.00556	CbGpPWpGaD
Antipyrine—CYP2D6—brainstem—brain cancer	0.000354	0.00582	CbGeAlD
Antipyrine—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000354	0.00548	CbGpPWpGaD
Antipyrine—CYP2B6—gonad—brain cancer	0.000353	0.0058	CbGeAlD
Antipyrine—CYP2C19—endocrine gland—brain cancer	0.000341	0.0056	CbGeAlD
Antipyrine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00034	0.00526	CbGpPWpGaD
Antipyrine—CYP2C18—Biological oxidations—CYP2C9—brain cancer	0.000321	0.00497	CbGpPWpGaD
Antipyrine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00032	0.00496	CbGpPWpGaD
Antipyrine—CYP2C18—Metapathway biotransformation—CYP2C9—brain cancer	0.000316	0.0049	CbGpPWpGaD
Antipyrine—CYP2D6—telencephalon—brain cancer	0.000315	0.00516	CbGeAlD
Antipyrine—CYP2E1—medulla oblongata—brain cancer	0.000312	0.00512	CbGeAlD
Antipyrine—PTGS1—pituitary gland—brain cancer	0.000312	0.00512	CbGeAlD
Antipyrine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00031	0.0048	CbGpPWpGaD
Antipyrine—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000306	0.00474	CbGpPWpGaD
Antipyrine—PTGS2—pituitary gland—brain cancer	0.000298	0.00489	CbGeAlD
Antipyrine—CYP2C8—endocrine gland—brain cancer	0.000298	0.00489	CbGeAlD
Antipyrine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000297	0.0046	CbGpPWpGaD
Antipyrine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000291	0.0045	CbGpPWpGaD
Antipyrine—PTGS2—medulla oblongata—brain cancer	0.000287	0.00472	CbGeAlD
Antipyrine—CYP1A2—endocrine gland—brain cancer	0.000279	0.00457	CbGeAlD
Antipyrine—CYP2E1—spinal cord—brain cancer	0.000278	0.00457	CbGeAlD
Antipyrine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000277	0.00429	CbGpPWpGaD
Antipyrine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000275	0.00426	CbGpPWpGaD
Antipyrine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000273	0.00423	CbGpPWpGaD
Antipyrine—TRPA1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000271	0.00419	CbGpPWpGaD
Antipyrine—PTGS1—spinal cord—brain cancer	0.000268	0.0044	CbGeAlD
Antipyrine—CYP2B6—endocrine gland—brain cancer	0.000267	0.00438	CbGeAlD
Antipyrine—CYP2C9—endocrine gland—brain cancer	0.000264	0.00434	CbGeAlD
Antipyrine—CYP2B6—head—brain cancer	0.000264	0.00433	CbGeAlD
Antipyrine—PTGS2—midbrain—brain cancer	0.000263	0.00431	CbGeAlD
Antipyrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000262	0.00406	CbGpPWpGaD
Antipyrine—PTGS2—spinal cord—brain cancer	0.000256	0.00421	CbGeAlD
Antipyrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000255	0.00394	CbGpPWpGaD
Antipyrine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000251	0.00389	CbGpPWpGaD
Antipyrine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000251	0.00389	CbGpPWpGaD
Antipyrine—CYP2E1—endocrine gland—brain cancer	0.000251	0.00411	CbGeAlD
Antipyrine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00025	0.00386	CbGpPWpGaD
Antipyrine—CYP2E1—head—brain cancer	0.000247	0.00406	CbGeAlD
Antipyrine—PTGS1—endocrine gland—brain cancer	0.000241	0.00396	CbGeAlD
Antipyrine—CYP2B6—central nervous system—brain cancer	0.000241	0.00395	CbGeAlD
Antipyrine—PTGS1—head—brain cancer	0.000238	0.00391	CbGeAlD
Antipyrine—PTGS2—endocrine gland—brain cancer	0.000231	0.00379	CbGeAlD
Antipyrine—PTGS2—head—brain cancer	0.000228	0.00374	CbGeAlD
Antipyrine—CYP2E1—central nervous system—brain cancer	0.000226	0.00371	CbGeAlD
Antipyrine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000224	0.00347	CbGpPWpGaD
Antipyrine—CYP2E1—cerebellum—brain cancer	0.000221	0.00362	CbGeAlD
Antipyrine—PTGS1—central nervous system—brain cancer	0.000218	0.00357	CbGeAlD
Antipyrine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000216	0.00334	CbGpPWpGaD
Antipyrine—CYP2C8—brain—brain cancer	0.000213	0.0035	CbGeAlD
Antipyrine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000213	0.0033	CbGpPWpGaD
Antipyrine—PTGS2—central nervous system—brain cancer	0.000208	0.00341	CbGeAlD
Antipyrine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000207	0.00321	CbGpPWpGaD
Antipyrine—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000207	0.0032	CbGpPWpGaD
Antipyrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000206	0.0032	CbGpPWpGaD
Antipyrine—PTGS2—cerebellum—brain cancer	0.000203	0.00334	CbGeAlD
Antipyrine—CYP3A4—endocrine gland—brain cancer	0.000202	0.00331	CbGeAlD
Antipyrine—CYP2D6—endocrine gland—brain cancer	0.000198	0.00326	CbGeAlD
Antipyrine—CYP2D6—head—brain cancer	0.000196	0.00322	CbGeAlD
Antipyrine—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000196	0.00303	CbGpPWpGaD
Antipyrine—CYP2B6—brain—brain cancer	0.000191	0.00314	CbGeAlD
Antipyrine—CYP3A4—central nervous system—brain cancer	0.000182	0.00298	CbGeAlD
Antipyrine—CYP2E1—brain—brain cancer	0.000179	0.00294	CbGeAlD
Antipyrine—CYP2D6—central nervous system—brain cancer	0.000179	0.00294	CbGeAlD
Antipyrine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000175	0.00271	CbGpPWpGaD
Antipyrine—CYP2D6—cerebellum—brain cancer	0.000175	0.00287	CbGeAlD
Antipyrine—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000174	0.00269	CbGpPWpGaD
Antipyrine—PTGS1—brain—brain cancer	0.000173	0.00284	CbGeAlD
Antipyrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000166	0.00258	CbGpPWpGaD
Antipyrine—PTGS2—brain—brain cancer	0.000165	0.00271	CbGeAlD
Antipyrine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000164	0.00254	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—GFAP—brain cancer	0.000162	0.00251	CbGpPWpGaD
Antipyrine—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000158	0.00244	CbGpPWpGaD
Antipyrine—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000156	0.00241	CbGpPWpGaD
Antipyrine—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000155	0.00239	CbGpPWpGaD
Antipyrine—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000152	0.00236	CbGpPWpGaD
Antipyrine—PTGS2—S1P1 pathway—VEGFA—brain cancer	0.000152	0.00235	CbGpPWpGaD
Antipyrine—PTGS2—C-MYB transcription factor network—CDK6—brain cancer	0.000142	0.0022	CbGpPWpGaD
Antipyrine—CYP2D6—brain—brain cancer	0.000142	0.00233	CbGeAlD
Antipyrine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000141	0.00219	CbGpPWpGaD
Antipyrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000135	0.00209	CbGpPWpGaD
Antipyrine—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000134	0.00207	CbGpPWpGaD
Antipyrine—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000132	0.00204	CbGpPWpGaD
Antipyrine—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—brain cancer	0.000127	0.00197	CbGpPWpGaD
Antipyrine—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	0.000127	0.00196	CbGpPWpGaD
Antipyrine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000125	0.00194	CbGpPWpGaD
Antipyrine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—brain cancer	0.000124	0.00192	CbGpPWpGaD
Antipyrine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000119	0.00185	CbGpPWpGaD
Antipyrine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000118	0.00182	CbGpPWpGaD
Antipyrine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000115	0.00178	CbGpPWpGaD
Antipyrine—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	0.000113	0.00174	CbGpPWpGaD
Antipyrine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.00011	0.0017	CbGpPWpGaD
Antipyrine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000108	0.00167	CbGpPWpGaD
Antipyrine—PTGS2—C-MYB transcription factor network—HES1—brain cancer	0.000105	0.00162	CbGpPWpGaD
Antipyrine—PTGS2—Selenium Micronutrient Network—SOD2—brain cancer	0.000101	0.00156	CbGpPWpGaD
Antipyrine—PTGS2—Aryl Hydrocarbon Receptor—RELA—brain cancer	9.77e-05	0.00151	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	9.58e-05	0.00148	CbGpPWpGaD
Antipyrine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	9.29e-05	0.00144	CbGpPWpGaD
Antipyrine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	9.16e-05	0.00142	CbGpPWpGaD
Antipyrine—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	8.78e-05	0.00136	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	8.72e-05	0.00135	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	8.27e-05	0.00128	CbGpPWpGaD
Antipyrine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	8.23e-05	0.00127	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.94e-05	0.00123	CbGpPWpGaD
Antipyrine—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	7.48e-05	0.00116	CbGpPWpGaD
Antipyrine—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	7.32e-05	0.00113	CbGpPWpGaD
Antipyrine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	7.17e-05	0.00111	CbGpPWpGaD
Antipyrine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	7.07e-05	0.00109	CbGpPWpGaD
Antipyrine—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	7.03e-05	0.00109	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	6.98e-05	0.00108	CbGpPWpGaD
Antipyrine—PTGS2—Aryl Hydrocarbon Receptor—MYC—brain cancer	6.88e-05	0.00106	CbGpPWpGaD
Antipyrine—PTGS2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	6.73e-05	0.00104	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.3e-05	0.000976	CbGpPWpGaD
Antipyrine—PTGS2—C-MYB transcription factor network—CDKN2A—brain cancer	6.27e-05	0.000971	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—CDK4—brain cancer	6.25e-05	0.000968	CbGpPWpGaD
Antipyrine—PTGS2—Selenium Micronutrient Network—RELA—brain cancer	5.81e-05	0.0009	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.81e-05	0.000899	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	5.73e-05	0.000888	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	5.62e-05	0.00087	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	5.55e-05	0.00086	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	5.53e-05	0.000856	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—CYP2C9—brain cancer	5.49e-05	0.00085	CbGpPWpGaD
Antipyrine—PTGS2—C-MYB transcription factor network—CCND1—brain cancer	5.3e-05	0.00082	CbGpPWpGaD
Antipyrine—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	5.2e-05	0.000805	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	5.16e-05	0.000799	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.13e-05	0.000794	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.98e-05	0.000771	CbGpPWpGaD
Antipyrine—PTGS2—Disease—DTX2—brain cancer	4.96e-05	0.000768	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	4.92e-05	0.000762	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—BSG—brain cancer	4.67e-05	0.000722	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.61e-05	0.000714	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.58e-05	0.000709	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	4.25e-05	0.000658	CbGpPWpGaD
Antipyrine—PTGS2—C-MYB transcription factor network—MYC—brain cancer	4.25e-05	0.000658	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.23e-05	0.000655	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—IL2—brain cancer	4.14e-05	0.000641	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—CCND1—brain cancer	4.04e-05	0.000625	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—IDH1—brain cancer	4.01e-05	0.000621	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	4e-05	0.00062	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.89e-05	0.000603	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.81e-05	0.000589	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.81e-05	0.000589	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.75e-05	0.000581	CbGpPWpGaD
Antipyrine—PTGS2—Disease—HES5—brain cancer	3.64e-05	0.000564	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.57e-05	0.000552	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—CYP2C9—brain cancer	3.54e-05	0.000547	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.35e-05	0.000518	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—CYP2C9—brain cancer	3.34e-05	0.000518	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—MYC—brain cancer	3.24e-05	0.000501	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—ENO2—brain cancer	3.17e-05	0.000491	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—EGFR—brain cancer	3.17e-05	0.00049	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.11e-05	0.000481	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.05e-05	0.000473	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—BSG—brain cancer	3.01e-05	0.000466	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—BSG—brain cancer	2.84e-05	0.00044	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—CYP2C9—brain cancer	2.81e-05	0.000435	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.75e-05	0.000425	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.72e-05	0.000421	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—CYP2C9—brain cancer	2.7e-05	0.000418	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—TP53—brain cancer	2.66e-05	0.000412	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—CYP2C9—brain cancer	2.64e-05	0.000409	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.61e-05	0.000404	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—IDH1—brain cancer	2.59e-05	0.0004	CbGpPWpGaD
Antipyrine—PTGS2—Disease—IDH1—brain cancer	2.45e-05	0.000379	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—IDH1—brain cancer	2.44e-05	0.000379	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.39e-05	0.000371	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—BSG—brain cancer	2.39e-05	0.00037	CbGpPWpGaD
Antipyrine—PTGS2—Disease—HEY1—brain cancer	2.32e-05	0.00036	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—BSG—brain cancer	2.29e-05	0.000355	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—CYP2C9—brain cancer	2.28e-05	0.000354	CbGpPWpGaD
Antipyrine—PTGS2—Disease—DLL1—brain cancer	2.28e-05	0.000353	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—BSG—brain cancer	2.25e-05	0.000348	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.2e-05	0.000341	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.15e-05	0.000334	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.11e-05	0.000326	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—IDH1—brain cancer	2.05e-05	0.000318	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—ENO2—brain cancer	2.04e-05	0.000316	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—CYP2C9—brain cancer	2.04e-05	0.000316	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—IDH1—brain cancer	1.97e-05	0.000305	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—BSG—brain cancer	1.94e-05	0.000301	CbGpPWpGaD
Antipyrine—PTGS2—Disease—SHH—brain cancer	1.94e-05	0.0003	CbGpPWpGaD
Antipyrine—PTGS2—Disease—ENO2—brain cancer	1.94e-05	0.0003	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—ENO2—brain cancer	1.93e-05	0.000299	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—IDH1—brain cancer	1.93e-05	0.000299	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.88e-05	0.00029	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.81e-05	0.00028	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—BSG—brain cancer	1.73e-05	0.000268	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.67e-05	0.000259	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—IDH1—brain cancer	1.67e-05	0.000259	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—ENO2—brain cancer	1.62e-05	0.000251	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—BSG—brain cancer	1.59e-05	0.000247	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.59e-05	0.000246	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—BSG—brain cancer	1.58e-05	0.000245	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—ENO2—brain cancer	1.56e-05	0.000241	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—ENO2—brain cancer	1.53e-05	0.000236	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—IDH1—brain cancer	1.49e-05	0.000231	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—PIK3CG—brain cancer	1.45e-05	0.000225	CbGpPWpGaD
Antipyrine—PTGS2—Disease—VAV1—brain cancer	1.4e-05	0.000217	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—IDH1—brain cancer	1.37e-05	0.000212	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.36e-05	0.000211	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—IDH1—brain cancer	1.36e-05	0.00021	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—BSG—brain cancer	1.35e-05	0.000209	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—ENO2—brain cancer	1.32e-05	0.000204	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.23e-05	0.00019	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.21e-05	0.000188	CbGpPWpGaD
Antipyrine—PTGS2—Disease—HES1—brain cancer	1.2e-05	0.000186	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—ENO2—brain cancer	1.18e-05	0.000182	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—IDH1—brain cancer	1.16e-05	0.00018	CbGpPWpGaD
Antipyrine—PTGS2—Disease—PDGFRA—brain cancer	1.15e-05	0.000177	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.11e-05	0.000171	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—ENO2—brain cancer	1.08e-05	0.000168	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—ENO2—brain cancer	1.07e-05	0.000166	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—BSG—brain cancer	1.04e-05	0.000161	CbGpPWpGaD
Antipyrine—PTGS2—Disease—IRS2—brain cancer	1.01e-05	0.000156	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.46e-06	0.000146	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PIK3CG—brain cancer	9.38e-06	0.000145	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ENO2—brain cancer	9.18e-06	0.000142	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—IDH1—brain cancer	8.96e-06	0.000139	CbGpPWpGaD
Antipyrine—PTGS2—Disease—APC—brain cancer	8.89e-06	0.000138	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PIK3CG—brain cancer	8.87e-06	0.000137	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PIK3CG—brain cancer	7.44e-06	0.000115	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PIK3CG—brain cancer	7.15e-06	0.000111	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ENO2—brain cancer	7.09e-06	0.00011	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PIK3CG—brain cancer	7.01e-06	0.000108	CbGpPWpGaD
Antipyrine—PTGS2—Disease—ERBB2—brain cancer	6.9e-06	0.000107	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PIK3CG—brain cancer	6.06e-06	9.38e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CTNNB1—brain cancer	6.04e-06	9.35e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PIK3CG—brain cancer	5.41e-06	8.37e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—STAT3—brain cancer	5.26e-06	8.15e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PIK3CG—brain cancer	4.97e-06	7.7e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.93e-06	7.63e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—MYC—brain cancer	4.89e-06	7.57e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—EGFR—brain cancer	4.78e-06	7.41e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PIK3CG—brain cancer	4.21e-06	6.52e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PIK3CG—brain cancer	3.25e-06	5.03e-05	CbGpPWpGaD
